Product NDC: | 17856-2002 |
Proprietary Name: | Chlorhexidine Gluconate |
Non Proprietary Name: | Chlorhexidine Gluconate |
Active Ingredient(s): | .12 mg/mL & nbsp; Chlorhexidine Gluconate |
Administration Route(s): | ORAL |
Dosage Form(s): | RINSE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17856-2002 |
Labeler Name: | Atlantic Biologicals Corps |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077789 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090801 |
Package NDC: | 17856-2002-3 |
Package Description: | 15 mL in 1 CUP (17856-2002-3) |
NDC Code | 17856-2002-3 |
Proprietary Name | Chlorhexidine Gluconate |
Package Description | 15 mL in 1 CUP (17856-2002-3) |
Product NDC | 17856-2002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlorhexidine Gluconate |
Dosage Form Name | RINSE |
Route Name | ORAL |
Start Marketing Date | 20090801 |
Marketing Category Name | ANDA |
Labeler Name | Atlantic Biologicals Corps |
Substance Name | CHLORHEXIDINE GLUCONATE |
Strength Number | .12 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Cell Wall Integrity [PE] |